LAMC2 and neoplasm: Quantitatively, silencing LAMC2 largely reduced the iCCA tumor burden, shown through remarkable decreases in liver/body ratios, tumor numbers, and tumor sizes in both iCCA models (p < 0.01 for each comparison).